accruwebmaster

About accruwebmaster

This author has not yet filled in any details.
So far accruwebmaster has created 109 blog entries.

ACCRU-SC-2102

Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide, a Cannabimimetic Nutraceutical: [...]

ACCRU-SC-21022022-07-19T14:08:03+00:00

RU241210I

Thyroid/Endocrine – Phase II Study of Cabozantinib in Patients with [...]

RU241210I2022-03-08T13:48:14+00:00

CE.6

Neuro Oncology – A Randomized Phase III Study of Temozolomide [...]

CE.62022-03-08T13:45:32+00:00

RU261206I

Melanoma – Randomized Phase II Study of AB (nab-paclitaxel Abraxane, [...]

RU261206I2022-03-08T13:43:58+00:00

ACCRU-MY-2101

Open label, phase 2, single arm Study testing the combination [...]

ACCRU-MY-21012022-03-08T03:16:35+00:00

ACCRU-MY-1901

Open Label, Phase 2, Single-Arm Study of Selinexor, Daratumumab, Carfilzomib [...]

ACCRU-MY-19012022-07-14T15:55:31+00:00

ACCRU-MY-1601

Phase 2 Trial of Daratumumab Retreatment in Patients with Relapsed [...]

ACCRU-MY-16012022-03-08T03:14:02+00:00

MC0485

A Phase II Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With [...]

MC04852022-03-08T03:02:07+00:00

RC0783

Randomized Phase II Trial of Pentostatin, Cyclophosphamide, and Rituximab With [...]

RC07832022-03-08T02:58:53+00:00
Go to Top